Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chlamydia trachomatis diagnostics.

M A Chernesky

    Sexually Transmitted Infections
    |August 16, 2002
    PubMed
    Summary
    This summary is machine-generated.

    Nucleic acid amplification (NAA) assays have been developed over the past 12 years for diagnosing Chlamydia trachomatis infections. Significant efforts have focused on creating and evaluating commercial NAA kits for infection diagnosis and treatment.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Molecular Diagnosis of Chlamydia trachomatis Infections by Probe Hybridization, PCR, LCR,TMA, and Q-β Replicase.

    Methods in molecular medicine·2011
    Same author

    Controversies in viral immunization.

    Canadian family physician Medecin de famille canadien·2011
    Same author

    Rubella testing and the pregnant patient.

    Canadian family physician Medecin de famille canadien·2010
    Same author

    Ability of new APTIMA CT and APTIMA GC assays to detect Chlamydia trachomatis and Neisseria gonorrhoeae in male urine and urethral swabs.

    Journal of clinical microbiology·2005
    Same author

    Collaborative multidisciplinary workshop report: detection, culture, serology, and antimicrobial susceptibility testing of Chlamydia pneumoniae.

    The Journal of infectious diseases·2000
    Same author

    Direct detection of vanA and vanB genes in clinical specimens for rapid identification of vancomycin resistant enterococci (VRE) using multiplex PCR.

    Molecular and cellular probes·1999
    Same journal

    Acceptability and use of doxyPEP among cisgender men who have sex with men, transgender women and non-binary persons assigned male sex at birth: results from a national online survey from the USA.

    Sexually transmitted infections·2026
    Same journal

    Cervicovaginal inflammation and HIV target cell activation in adolescent girls and young women with <i>Chlamydia trachomatis</i> infections.

    Sexually transmitted infections·2026
    Same journal

    Cost-effectiveness of a decentralised molecular point-of-care testing programme for sexually transmitted infections in remote primary care health services in Australia.

    Sexually transmitted infections·2026
    Same journal

    Insights into sexual partners and partnerships among gay, bisexual and other men who have sex with men in the United Kingdom: results from the Reducing Inequalities in Sexual Health (RiiSH) behavioural survey.

    Sexually transmitted infections·2026
    Same journal

    Deep genomic characterisation of an extensively drug-resistant <i>Shigella sonnei</i> carrying bla <i><sub>CTX-M-15</sub></i> in a sexually transmitted infection in an MSM patient in Spain.

    Sexually transmitted infections·2026
    Same journal

    National prevalence estimates of chlamydia and gonorrhoea in the Netherlands (PECAN): comparison of two national cross-sectional surveys.

    Sexually transmitted infections·2026
    See all related articles

    Area of Science:

    • Microbiology
    • Infectious Diseases
    • Molecular Diagnostics

    Background:

    • Chlamydia trachomatis is a common bacterial pathogen causing sexually transmitted infections.
    • Accurate and timely diagnosis is crucial for effective treatment and prevention of complications.
    • Nucleic acid amplification (NAA) assays have emerged as a primary diagnostic tool.

    Purpose of the Study:

    • To review the development and evaluation of NAA assays for Chlamydia trachomatis diagnosis.
    • To highlight the progress in commercial NAA kit development over the last 12 years.

    Main Methods:

    • Literature review of peer-reviewed publications on NAA assays for Chlamydia trachomatis.
    • Analysis of the evolution and evaluation of commercially available NAA kits.

    Related Experiment Videos

    Main Results:

    • NAA assays for Chlamydia trachomatis diagnosis have been available for approximately 12 years.
    • There has been substantial investment in developing and assessing commercial NAA kits.
    • These kits are integral to diagnosing and managing Chlamydia trachomatis infections.

    Conclusions:

    • NAA assays represent a significant advancement in Chlamydia trachomatis diagnostics.
    • Commercial NAA kits have become widely adopted for clinical use.
    • Continued development and evaluation of these assays are essential for public health.